ACRV
Acrivon TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ACRV fundamentals
Acrivon Therapeutics (ACRV) released its earnings on Nov 13, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.47 (YoY +20.34%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.47
+20.34%
Report date
Nov 13, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Acrivon Therapeutics (ACRV) key financial stats and ratios, covering profitability, financial health, and leverage.
Acrivon Therapeutics (ACRV)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Acrivon Therapeutics (ACRV)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Acrivon Therapeutics (ACRV)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Acrivon Therapeutics (ACRV) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Acrivon Therapeutics (ACRV) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
